| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 25787-43-3 | Adenosine,3'-deoxy-3'-(methylamino)- (8CI,9CI); 3'-N-Methylamino-3'-deoxyadenosine; NSC 128889 |  | C11H16N6O3 | 詳情 | 供應商 | |
| 6088-33-1 | Adenosine,3'-amino-3'-deoxy-N-methyl- (6CI,7CI,8CI,9CI); 6-Methylamino-9-(3'-amino-3'-deoxy-b-D-ribofuranosyl)purine; 9-(3'-Amino-3'-deoxy-b-D-ribofuranosyl)-6-methylamino-9H-purine; N6-Methyl-3'-amino-3'-deoxyadenosine |  | C11H16N6O3 | 詳情 | 供應商 | |
| 108895-46-1 | Cytidine,3'-azido-2',3'-dideoxy-N,5-dimethyl- |  | C11H16N6O3 | 詳情 | 供應商 | |
| 129570-24-7 | L-Cysteine,S-[2-(2-amino-1,6-dihydro-6-oxo-7H-purin-7-yl)ethyl]-, methyl ester |  | C11H16N6O3S | 詳情 | 供應商 | |
| 25575-89-7 | L-Histidine,N-(5-oxo-L-prolyl)-, hydrazide (9CI); Histidine,N-(5-oxo-L-prolyl)-, hydrazide, L- (8CI); L-Pyroglutamyl-L-histidine hydrazide |  | C11H16N6O3 | 詳情 | 供應商 | |
| 108742-10-5 | 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1R,2R,3S,5S)-rel-; 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1a,2b,3a,5a)- (9CI); 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1a,2b,3a,5a)-(?à)- |  | C11H16N6O3 | 詳情 | 供應商 | |
| 125073-27-0 | 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1R,2S,3S,5S)-rel-; 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1a,2a,3a,5a)- (9CI); 1,2-Cyclopentanediol,3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1a,2a,3a,5a)-(?à)- |  | C11H16N6O3 | 詳情 | 供應商 | |
| 249503-32-0 | 3,4-Pyrrolidinediol,2-[(6-amino-9H-purin-9-yl)methyl]-5-(hydroxymethyl)-, (2S,3S,4R,5R)-; 3,4-Pyrrolidinediol, 2-(6-amino-9H-purin-9-yl)methyl-5-(hydroxymethyl)-, (2S,3S,4R,5R)- |  | C11H16N6O3 | 詳情 | 供應商 |